MARKET

REVB

REVB

Revelation Biosciences
NASDAQ
0.9793
-0.0507
-4.92%
After Hours: 0.9796 +0.0003 +0.03% 18:22 05/15 EDT
OPEN
1.022
PREV CLOSE
1.030
HIGH
1.030
LOW
0.9600
VOLUME
90.80K
TURNOVER
--
52 WEEK HIGH
40.08
52 WEEK LOW
0.8750
MARKET CAP
3.83M
P/E (TTM)
-0.0248
1D
5D
1M
3M
1Y
5Y
1D
Revelation Biosciences reports FY25 EPS ($14.35) vs ($1,052.16) last year
TipRanks · 5d ago
Weekly Report: what happened at REVB last week (0504-0508)?
Weekly Report · 5d ago
Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Enovis (ENOV) and Revelation Biosciences (REVB)
TipRanks · 05/08 17:31
Watching Revelation Biosciences; Zacks Small-Cap Research Gives Stock $22.50 Price Valuation
Benzinga · 05/08 16:05
Revelation Biosciences GAAP EPS of -$2.71
Seeking Alpha · 05/08 10:55
Revelation Biosciences Q1 net loss widens as expenses rise
Reuters · 05/07 20:50
Revelation Biosciences Q1 2026 net loss widens to $3.01 million
PUBT · 05/07 20:36
Weekly Report: what happened at REVB last week (0427-0501)?
Weekly Report · 05/04 10:24
More
About REVB
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. The Company's product candidates are based on the Gemini formulation of phosphorylated hexaacyl disaccharide (PHAD). The Company has multiple ongoing programs to evaluate Gemini, including GEM-AKI as a prevention of acute kidney injury (AKI), GEM-CKD as a treatment for chronic kidney disease (CKD), and GEM-PSI as a prevention of post-surgical infection (PSI). The Gemini-AKI program is being developed as a potential therapy for the prevention of AKI due to external stress or insult, such as surgical procedure and chemotherapy toxicity. GEM-PSI is being developed as a potential therapy for the prevention or treatment of healthcare-associated bacterial infections, including post-surgical infection, post-burn infection, urinary tract infection, sepsis, and antibiotic-resistant infection.

Webull offers Revelation Biosciences Inc stock information, including NASDAQ: REVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REVB stock methods without spending real money on the virtual paper trading platform.